iCCAUniversity Hospital of Bordeauxtargeted therapylocally advanced or metastatic cholangiocarcinomaCCA
…localisations), and 11.4% received targeted therapy (15.5% with iCCA and 2.5% with other localisations). No significant benefit in O…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: iCCA ×
iCCA
This drug is selected. Its supporting articles are shown below.